Real-time quantitation of viral replication and inhibitor potency using a label-free optical biosensor

References

• Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME, McClelland A. The major human rhinovirus receptor is ICAM-1. Cell 1989, 56, 839–847.
   PubMed Web of Science ®Google Scholar
• Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989, 56, 849–853.
   PubMed Web of Science ®Google Scholar
• Yamaya M, Sasaki H. Rhinovirus and asthma. Viral Immunol 2003, 16, 99–109.
   Google Scholar
• Gwaltney Jr JM, Hendley JO, Simon G, Jordan Jr WS, Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med 1966, 275, 1261–1268.
   PubMed Web of Science ®Google Scholar
• Tyrrell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect 1993, 111, 143–156.
   PubMed Web of Science ®Google Scholar
• Winther B, Gwaltney Jr JM, Mygind N, Turner RB, Hendley JO. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 1986, 256, 1763–1767.
   PubMed Web of Science ®Google Scholar
• Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B, Hayden FG. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 1999, 281, 1797–1804.
   PubMed Web of Science ®Google Scholar
• Kilby JM, Eron JJ. Novel therapies based on mechanisms of HIV-1 cell entry. N Engl J Med 2003, 348, 2228–2238.
   PubMed Web of Science ®Google Scholar
• Colonno RJ, Callahan PL, Long WJ. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J Virol 1986, 57, 7–12.
   Google Scholar
• Hayden FG, Gwaltney JM, Jr., Colonno RJ. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res 1988, 9, 233–247.
   PubMed Web of Science ®Google Scholar
• Hayden FG, Andries K, Janssen PA. Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob Agents Chemother 1992, 36, 727–732.
   PubMed Web of Science ®Google Scholar
• Hayden FG, Turner RB, Gwaltney JM, Chi-Burris K, Gersten M, Hsyu P, Patick AK, Smith 3rd GJ, Zalman LS. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 2003, 47, 3907–3916.
   PubMed Web of Science ®Google Scholar
• Murray MA, Babe LM. Inhibitory effect of dibenzofuran and dibenzosuberol derivatives on rhinovirus replication in vitro; effective prevention of viral entry by dibenzosuberenone. Antiviral Research 1999, 44, 123–131.
   Google Scholar
• Sasaki T, Yamaya M, Yasuda H, Inoue D, Yamada M, Kubo H, Nishimura H, Sasaki H. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. Eur J Pharmacol 2005, 509, 201–210.
   Google Scholar
• Fang Y, Li GS, Peng JL. Optical biosensor provides insights for bradykinin B-2 receptor signaling in A431 cells. Febs Letters 2005, 579, 6365–6374.
   PubMed Web of Science ®Google Scholar
• Lee PH, Gao A, van Staden C, Ly J, Salon J, Xu A, Fang Y, Verkleeren R. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors. Assay Drug Dev Technol 2008, 6, 83–94.
   PubMed Web of Science ®Google Scholar
• Fang Y, Ferrie AM, Fontaine NH, Yuen PK. Characteristics of dynamic mass redistribution of epidermal growth factor receptor signaling in living cells measured with label-free optical biosensors. Anal Chem 2005, 77, 5720–5725.
   PubMed Web of Science ®Google Scholar
• Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990, 344, 70–72.
   PubMed Web of Science ®Google Scholar
• Argenbright LW, Letts LG, Rothlein R. Monoclonal-antibodies to the leukocyte membrane Cd18 glycoprotein complex and to intercellular-adhesion molecule-1 inhibit leukocyte- endothelial adhesion in rabbits. J Leukocyte Biol 1991, 49, 253–257.
   PubMed Web of Science ®Google Scholar
• Oliveira, MA, Zhao R, Lee W, Kremer MJ, Minor I, Rueckert RR, Diana GD, Pevear DC, Dutko FJ, McKinlay MA, Rossmann MG. The structure of human rhinovirus 16. Structure 1993, 1, 51–68.
   PubMed Web of Science ®Google Scholar
• Rueckert RR, Pallansch MA. Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol 1981, 78, 315–325.
   PubMedGoogle Scholar
• Fang Y. Label-free cell-based assays with optical biosensors in drug discovery. Assay Drug Devel Technol 2006, 4, 583–595.
   PubMed Web of Science ®Google Scholar
• Rueckert RR. (1996). Picornaviridae: the viruses and their replication. (Philadelphia, USA: Lippincott-Raven Publishers ).
   Google Scholar
• Makgoba MW, Sanders ME, Luce GEG, Dustin ML, Springer TA, Clark EA, Mannoni P, Shaw S. Icam-1 a ligand for Lfa-1-dependent adhesion of B-cells, T-cells and myeloid cells. Nature 1988, 331, 86–88.
   PubMed Web of Science ®Google Scholar
• Greve JM, Forte CP, Marlor CW, Meyer AM, Hoover-Litty H, Wunderlich D, McClelland A. Mechanisms of receptor- mediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J Virol 1991, 65, 6015–6023.
   PubMed Web of Science ®Google Scholar
• Butterworth BE, Grunert RR, Korant BD, Lonbergholm K, Yin FH. Replication of Rhinoviruses – Brief Review. Archives of Virology 1976, 51, 169–189.
   Google Scholar
• Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang XW, Hogle JM. Imaging poliovirus entry in live cells. Plos Biology 2007, 5, 1543–1555.
   Google Scholar
• Dunnebac Th, Levintha Jd, Williams RC. Entry and release of poliovirus as observed by electron microscopy of cultured cells. J Virology 1969, 4, 505.
   Google Scholar